Trademark: MILLENNIUM 924614
Word
MILLENNIUM
ID
924614
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
26 August 2002
Registration Date
09 August 2001
Renewal Date
09 August 2031
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 42:
Medical and diagnostic services, including, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, including, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, including, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, including, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, including, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology
Medical and diagnostic services, including, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, including, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, including, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, including, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, including, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology